Physician profile
Mark J Morris
NPI 1689672685
$1,018.14
in general payments reported to CMS, 2019-2025
17 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.71 · 2020: $19.50 · 2021: $27.58 · 2022: $104 · 2023: $253 · 2024: $229 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $164.96 | 2019-2025 | Clareon, Argos, Verion |
| Carl Zeiss Meditec USA, INC. | $152.40 | 2023 | Lumera 700 |
| Dompe US, INC. | $117.68 | 2024-2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $103.73 | 2024-2025 | Acthar |
| Astellas Pharma US INC | $69.80 | 2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $64.99 | 2022-2024 | Eylea Hd |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Amgen INC. | $56.38 | 2024-2025 | Tepezza |
| Harrow Eye, LLC | $49.48 | 2024 | Iheezo, Vevye |
| Bausch & Lomb Americas INC. | $49.30 | 2022-2025 | Xiidra, Miebo |
| Horizon Therapeutics Plc | $30.05 | 2023 | Tepezza |
| Glaukos Corporation | $19.50 | 2020 | |
| Lensar, INC. | $17.11 | 2025 | Lensar Laser System |
| Merz Pharmaceuticals, LLC | $15.81 | 2024 | Xeomin |
| Abbvie INC. | $14.66 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.34 | 2021 | |
| Aerie Pharmaceuticals, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.